Effectiveness of Dimethyl Fumarate in Patients With Relapsing Multiple Sclerosis Switching After Suboptimal Response to Glatiramer Acetate, Including Patients With Early Multiple Sclerosis: Subgroup Analysis of RESPOND

ConclusionsDMF may be an effective treatment option in first switch and early MS switch patients with RMS who experience a suboptimal response to GA.Trial RegistrationClinicalTrials.gov identifier: NCT01903291.
Source: Neurology and Therapy - Category: Neurology Source Type: research